Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Hepatocellular | 39 | 2024 | 2334 | 6.130 |
Why?
|
Liver Neoplasms | 43 | 2024 | 4363 | 5.440 |
Why?
|
Liver Cirrhosis | 39 | 2024 | 1960 | 4.660 |
Why?
|
Hepatitis C, Chronic | 10 | 2020 | 1032 | 2.370 |
Why?
|
Aspirin | 11 | 2024 | 3135 | 2.350 |
Why?
|
Fatty Liver | 3 | 2024 | 810 | 1.710 |
Why?
|
Liver | 16 | 2024 | 7578 | 1.500 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2023 | 3251 | 1.100 |
Why?
|
Hepatitis B, Chronic | 2 | 2020 | 413 | 0.980 |
Why?
|
Liver Diseases | 3 | 2024 | 1305 | 0.940 |
Why?
|
GTP-Binding Proteins | 2 | 2019 | 948 | 0.920 |
Why?
|
Antiviral Agents | 8 | 2025 | 3072 | 0.920 |
Why?
|
Sweden | 10 | 2022 | 1382 | 0.900 |
Why?
|
End Stage Liver Disease | 3 | 2024 | 370 | 0.880 |
Why?
|
Cardiovascular Diseases | 14 | 2022 | 15662 | 0.870 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2021 | 1126 | 0.810 |
Why?
|
Adiposity | 4 | 2021 | 1895 | 0.750 |
Why?
|
Risk Factors | 51 | 2025 | 74944 | 0.740 |
Why?
|
Somatotypes | 1 | 2020 | 39 | 0.720 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5176 | 0.710 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 76 | 0.710 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 144 | 0.690 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 972 | 0.690 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1119 | 0.670 |
Why?
|
Biliary Tract Neoplasms | 4 | 2023 | 187 | 0.660 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6568 | 0.650 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 215 | 0.640 |
Why?
|
Peritonitis | 1 | 2021 | 368 | 0.640 |
Why?
|
Biopsy | 13 | 2024 | 6792 | 0.630 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.630 |
Why?
|
Warfarin | 2 | 2024 | 1493 | 0.620 |
Why?
|
Eicosanoids | 1 | 2020 | 284 | 0.610 |
Why?
|
Dyslipidemias | 2 | 2016 | 873 | 0.610 |
Why?
|
Coffee | 3 | 2023 | 594 | 0.600 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 12252 | 0.600 |
Why?
|
Proportional Hazards Models | 17 | 2022 | 12543 | 0.590 |
Why?
|
Cohort Studies | 27 | 2024 | 41753 | 0.580 |
Why?
|
Metabolic Diseases | 1 | 2023 | 684 | 0.560 |
Why?
|
Simvastatin | 1 | 2019 | 346 | 0.560 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2021 | 317 | 0.550 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 625 | 0.550 |
Why?
|
Obesity | 12 | 2023 | 13091 | 0.540 |
Why?
|
Humans | 114 | 2025 | 768171 | 0.530 |
Why?
|
Middle Aged | 65 | 2024 | 223487 | 0.510 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2271 | 0.510 |
Why?
|
Hepatitis, Autoimmune | 3 | 2023 | 173 | 0.510 |
Why?
|
Fluorenes | 2 | 2017 | 160 | 0.490 |
Why?
|
Heart Arrest | 2 | 2023 | 1515 | 0.490 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 67 | 0.490 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39354 | 0.480 |
Why?
|
Incidence | 17 | 2023 | 21538 | 0.480 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.480 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1179 | 0.480 |
Why?
|
Adult | 52 | 2024 | 223646 | 0.470 |
Why?
|
Prospective Studies | 30 | 2024 | 54924 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1810 | 0.460 |
Why?
|
Fibrosis | 5 | 2023 | 2081 | 0.450 |
Why?
|
Hepacivirus | 3 | 2015 | 1344 | 0.440 |
Why?
|
Clostridium perfringens | 1 | 2013 | 29 | 0.440 |
Why?
|
Pyrazoles | 1 | 2024 | 2028 | 0.440 |
Why?
|
Female | 74 | 2024 | 397187 | 0.440 |
Why?
|
Weight Gain | 2 | 2021 | 2359 | 0.440 |
Why?
|
Heart Failure | 4 | 2022 | 11879 | 0.430 |
Why?
|
Primary Prevention | 1 | 2020 | 1188 | 0.410 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3109 | 0.410 |
Why?
|
Male | 66 | 2024 | 364731 | 0.410 |
Why?
|
Aged | 42 | 2024 | 171502 | 0.400 |
Why?
|
Stroke | 4 | 2024 | 9755 | 0.400 |
Why?
|
Hemorrhage | 1 | 2024 | 3466 | 0.390 |
Why?
|
Secondary Prevention | 1 | 2018 | 1474 | 0.390 |
Why?
|
Anticoagulants | 2 | 2024 | 4850 | 0.380 |
Why?
|
Hemolysis | 1 | 2013 | 417 | 0.370 |
Why?
|
Benzimidazoles | 2 | 2017 | 864 | 0.370 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2138 | 0.360 |
Why?
|
Diet | 7 | 2023 | 8089 | 0.360 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2020 | 2763 | 0.350 |
Why?
|
Resuscitation | 1 | 2015 | 679 | 0.350 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2496 | 0.340 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.340 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1282 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2298 | 0.310 |
Why?
|
Hepatitis C | 2 | 2015 | 1595 | 0.310 |
Why?
|
Blood Transfusion | 1 | 2015 | 1309 | 0.300 |
Why?
|
Catheterization | 1 | 2013 | 1430 | 0.300 |
Why?
|
Interleukin-6 | 1 | 2018 | 3229 | 0.300 |
Why?
|
Drug Costs | 1 | 2015 | 1195 | 0.280 |
Why?
|
Propensity Score | 4 | 2024 | 1969 | 0.270 |
Why?
|
Insulin Resistance | 2 | 2021 | 3986 | 0.270 |
Why?
|
Risk Assessment | 12 | 2025 | 24318 | 0.270 |
Why?
|
Body Mass Index | 9 | 2021 | 13053 | 0.270 |
Why?
|
Aspartate Aminotransferases | 2 | 2019 | 414 | 0.270 |
Why?
|
Clostridium Infections | 1 | 2013 | 562 | 0.270 |
Why?
|
Bacteremia | 1 | 2013 | 985 | 0.270 |
Why?
|
Cross Infection | 1 | 2015 | 1425 | 0.260 |
Why?
|
Bile Duct Neoplasms | 3 | 2023 | 614 | 0.260 |
Why?
|
Nurses | 3 | 2021 | 2501 | 0.260 |
Why?
|
Crohn Disease | 1 | 2018 | 2295 | 0.250 |
Why?
|
Registries | 6 | 2022 | 8375 | 0.250 |
Why?
|
Disease Progression | 7 | 2023 | 13668 | 0.240 |
Why?
|
Lipid Metabolism | 3 | 2024 | 1904 | 0.240 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 561 | 0.230 |
Why?
|
Heart | 1 | 2017 | 4446 | 0.230 |
Why?
|
Exercise | 2 | 2023 | 5954 | 0.230 |
Why?
|
United States | 19 | 2024 | 73039 | 0.230 |
Why?
|
Virus Activation | 1 | 2025 | 324 | 0.210 |
Why?
|
Severity of Illness Index | 8 | 2022 | 15949 | 0.210 |
Why?
|
Hepatitis, Viral, Human | 1 | 2023 | 141 | 0.200 |
Why?
|
Comorbidity | 6 | 2021 | 10590 | 0.200 |
Why?
|
Gallbladder Neoplasms | 2 | 2023 | 190 | 0.200 |
Why?
|
Tea | 1 | 2023 | 289 | 0.200 |
Why?
|
Death Certificates | 1 | 2023 | 172 | 0.200 |
Why?
|
Bradycardia | 1 | 2023 | 305 | 0.190 |
Why?
|
Ascites | 2 | 2021 | 338 | 0.190 |
Why?
|
Biliary Tract | 1 | 2022 | 135 | 0.190 |
Why?
|
Life Style | 3 | 2022 | 3932 | 0.190 |
Why?
|
Hepatitis B virus | 1 | 2025 | 533 | 0.180 |
Why?
|
Colitis, Lymphocytic | 1 | 2021 | 23 | 0.180 |
Why?
|
Colitis, Collagenous | 1 | 2021 | 25 | 0.180 |
Why?
|
Feeding Behavior | 3 | 2022 | 3205 | 0.180 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7477 | 0.180 |
Why?
|
Embolism | 1 | 2024 | 401 | 0.180 |
Why?
|
Laxatives | 1 | 2021 | 95 | 0.180 |
Why?
|
Prevalence | 5 | 2021 | 15869 | 0.180 |
Why?
|
Sports Medicine | 1 | 2023 | 239 | 0.170 |
Why?
|
Nuts | 2 | 2019 | 264 | 0.170 |
Why?
|
Case-Control Studies | 10 | 2024 | 22290 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 16044 | 0.170 |
Why?
|
Clinical Coding | 1 | 2021 | 188 | 0.170 |
Why?
|
Gallstones | 1 | 2022 | 285 | 0.170 |
Why?
|
Double-Blind Method | 3 | 2024 | 12466 | 0.170 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 220 | 0.160 |
Why?
|
Gastrointestinal Motility | 1 | 2021 | 235 | 0.160 |
Why?
|
Hepatitis B | 1 | 2025 | 711 | 0.160 |
Why?
|
Waist Circumference | 2 | 2020 | 935 | 0.160 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 181 | 0.160 |
Why?
|
Young Adult | 9 | 2024 | 60066 | 0.160 |
Why?
|
Alcohol Drinking | 3 | 2020 | 4045 | 0.160 |
Why?
|
Catheter Ablation | 1 | 2012 | 2780 | 0.160 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 190 | 0.160 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2021 | 162 | 0.160 |
Why?
|
Massachusetts | 3 | 2021 | 8890 | 0.150 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12077 | 0.150 |
Why?
|
Dietary Fiber | 2 | 2019 | 767 | 0.150 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 395 | 0.150 |
Why?
|
Inflammation | 4 | 2024 | 10873 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 483 | 0.150 |
Why?
|
Logistic Models | 4 | 2024 | 13290 | 0.150 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.150 |
Why?
|
Thiazolidinediones | 1 | 2021 | 461 | 0.150 |
Why?
|
International Classification of Diseases | 1 | 2024 | 937 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 402 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2020 | 553 | 0.150 |
Why?
|
Diet Surveys | 1 | 2021 | 1160 | 0.140 |
Why?
|
Obesity, Abdominal | 2 | 2021 | 375 | 0.140 |
Why?
|
Human Growth Hormone | 1 | 2022 | 651 | 0.140 |
Why?
|
Prognosis | 8 | 2021 | 30009 | 0.140 |
Why?
|
Age of Onset | 2 | 2021 | 3346 | 0.140 |
Why?
|
Adolescent | 9 | 2024 | 89169 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10763 | 0.140 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59626 | 0.140 |
Why?
|
Retrospective Studies | 10 | 2023 | 81760 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1535 | 0.140 |
Why?
|
Overweight | 3 | 2023 | 2448 | 0.130 |
Why?
|
Platelet Count | 1 | 2019 | 787 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 707 | 0.130 |
Why?
|
Hormones | 1 | 2020 | 866 | 0.130 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26379 | 0.130 |
Why?
|
Hyperammonemia | 1 | 2017 | 80 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2442 | 0.130 |
Why?
|
Dairy Products | 1 | 2019 | 490 | 0.130 |
Why?
|
Reproduction | 1 | 2020 | 646 | 0.130 |
Why?
|
Benzamides | 1 | 2021 | 1379 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2016 | 190 | 0.120 |
Why?
|
Consensus | 2 | 2024 | 3211 | 0.120 |
Why?
|
Diastole | 1 | 2017 | 785 | 0.120 |
Why?
|
Administration, Oral | 1 | 2023 | 4034 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 2017 | 606 | 0.120 |
Why?
|
Paracentesis | 1 | 2015 | 99 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1320 | 0.120 |
Why?
|
Anthropometry | 1 | 2019 | 1346 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1197 | 0.110 |
Why?
|
Glutamine | 1 | 2017 | 577 | 0.110 |
Why?
|
Piperacillin | 1 | 2013 | 37 | 0.110 |
Why?
|
Thrombophilia | 1 | 2016 | 308 | 0.110 |
Why?
|
Penicillanic Acid | 1 | 2013 | 41 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5432 | 0.110 |
Why?
|
Risk | 3 | 2020 | 9613 | 0.110 |
Why?
|
Coma | 1 | 2017 | 485 | 0.110 |
Why?
|
Clindamycin | 1 | 2013 | 138 | 0.110 |
Why?
|
Blood Component Transfusion | 1 | 2013 | 141 | 0.100 |
Why?
|
Walking | 1 | 2020 | 1201 | 0.100 |
Why?
|
Genotype | 2 | 2019 | 13045 | 0.100 |
Why?
|
Internationality | 1 | 2018 | 1008 | 0.100 |
Why?
|
Algorithms | 2 | 2024 | 14164 | 0.100 |
Why?
|
Albumins | 1 | 2015 | 577 | 0.100 |
Why?
|
Rhode Island | 1 | 2012 | 352 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1918 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2518 | 0.090 |
Why?
|
Osteoporosis | 1 | 2021 | 1605 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2017 | 3433 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3912 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4627 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 506 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14729 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1829 | 0.080 |
Why?
|
Lipids | 2 | 2022 | 3345 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3721 | 0.080 |
Why?
|
Survival Rate | 4 | 2020 | 12840 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 888 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2020 | 304 | 0.080 |
Why?
|
Indoles | 1 | 2016 | 1836 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6894 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2973 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6340 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13586 | 0.070 |
Why?
|
DNA, Viral | 1 | 2014 | 2204 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2666 | 0.070 |
Why?
|
Virus Replication | 1 | 2015 | 2458 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4861 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3782 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3629 | 0.060 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1761 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6610 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9384 | 0.060 |
Why?
|
Child | 3 | 2022 | 80917 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1942 | 0.060 |
Why?
|
Survival Analysis | 2 | 2021 | 10099 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14783 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2013 | 1240 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5047 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3941 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4428 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5442 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7243 | 0.060 |
Why?
|
Vegetables | 2 | 2020 | 1199 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4887 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 22371 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2517 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9092 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3239 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8741 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2019 | 2923 | 0.050 |
Why?
|
Sex Factors | 3 | 2020 | 10632 | 0.050 |
Why?
|
Dietary Fats | 2 | 2020 | 2003 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8543 | 0.050 |
Why?
|
Growth Hormone | 1 | 2023 | 573 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2023 | 309 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7454 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2017 | 65379 | 0.040 |
Why?
|
Time Factors | 3 | 2020 | 40220 | 0.040 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18065 | 0.040 |
Why?
|
Chemoprevention | 1 | 2022 | 327 | 0.040 |
Why?
|
Poultry | 1 | 2019 | 79 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 50 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 890 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2022 | 4541 | 0.040 |
Why?
|
Meat Products | 1 | 2019 | 97 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 171 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 121 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 150 | 0.040 |
Why?
|
Autopsy | 1 | 2023 | 1011 | 0.040 |
Why?
|
Republic of Korea | 1 | 2021 | 591 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 288 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2019 | 155 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2019 | 520 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2019 | 223 | 0.040 |
Why?
|
Gastroenterology | 1 | 2025 | 593 | 0.040 |
Why?
|
2-Naphthylamine | 1 | 2017 | 20 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1014 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2017 | 67 | 0.040 |
Why?
|
Sodium Benzoate | 1 | 2017 | 14 | 0.040 |
Why?
|
Glycemic Index | 1 | 2019 | 400 | 0.040 |
Why?
|
Phenylacetates | 1 | 2017 | 112 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3814 | 0.030 |
Why?
|
Medicare | 1 | 2015 | 6809 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36741 | 0.030 |
Why?
|
Fishes | 1 | 2019 | 606 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6316 | 0.030 |
Why?
|
Siblings | 1 | 2020 | 828 | 0.030 |
Why?
|
Uracil | 1 | 2017 | 210 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2017 | 436 | 0.030 |
Why?
|
Carbamates | 1 | 2017 | 192 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 581 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15453 | 0.030 |
Why?
|
Valine | 1 | 2017 | 410 | 0.030 |
Why?
|
Proline | 1 | 2017 | 455 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 319 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6525 | 0.030 |
Why?
|
Glutamates | 1 | 2017 | 385 | 0.030 |
Why?
|
Ritonavir | 1 | 2017 | 332 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1699 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 863 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 413 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 788 | 0.030 |
Why?
|
Interferons | 1 | 2018 | 720 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2596 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20225 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1140 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17569 | 0.030 |
Why?
|
Fruit | 1 | 2019 | 1165 | 0.030 |
Why?
|
Animals | 4 | 2021 | 169285 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18415 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1542 | 0.030 |
Why?
|
Cesarean Section | 1 | 2021 | 1425 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2025 | 3706 | 0.030 |
Why?
|
Lymphoma | 1 | 2022 | 1898 | 0.030 |
Why?
|
Societies, Medical | 1 | 2025 | 3968 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 644 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1422 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 748 | 0.020 |
Why?
|
Menopause | 1 | 2020 | 1656 | 0.020 |
Why?
|
Bariatric Surgery | 1 | 2022 | 1001 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2629 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10840 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2118 | 0.020 |
Why?
|
Lipoproteins | 1 | 2015 | 880 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2972 | 0.020 |
Why?
|
Trauma Centers | 1 | 2016 | 951 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27362 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30255 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1820 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3334 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 824 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2464 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3573 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4415 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1982 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5107 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2914 | 0.020 |
Why?
|
Viral Load | 1 | 2015 | 3396 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8648 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9374 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2755 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16726 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5863 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3800 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5349 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26421 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12795 | 0.010 |
Why?
|
Veterans | 1 | 2015 | 2669 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11519 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8080 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42669 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20762 | 0.010 |
Why?
|